Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Integra Lifesciences (IART)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,349,291
  • Shares Outstanding, K 85,180
  • Annual Sales, $ 1,188 M
  • Annual Income, $ 64,740 K
  • 36-Month Beta 0.89
  • Price/Sales 2.98
  • Price/Cash Flow 16.22
  • Price/Book 3.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.62
  • Number of Estimates 9
  • High Estimate 0.64
  • Low Estimate 0.59
  • Prior Year 0.64
  • Growth Rate Est. (year over year) -3.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.07 +13.29%
on 01/24/19
51.25 -0.37%
on 02/15/19
+5.19 (+11.31%)
since 01/15/19
3-Month
42.14 +21.17%
on 01/03/19
54.73 -6.71%
on 11/19/18
-2.41 (-4.51%)
since 11/15/18
52-Week
42.14 +21.17%
on 01/03/19
67.50 -24.36%
on 06/18/18
-0.37 (-0.72%)
since 02/15/18

Most Recent Stories

More News
Integra LifeSciences (IART) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Integra (IART) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IART : 51.06 (+0.81%)
Downtrend Call Working As Integra Lifescie Stock Falls 21.0% (IART)

SmarTrend identified a Downtrend for Integra Lifescie (NASDAQ:IART) on October 11th, 2018 at $60.49. In approximately 4 months, Integra Lifescie has returned 21.01% as of today's recent price of $47.78....

IART : 51.06 (+0.81%)
Integra LifeSciences Unveils Titan RSS-S, Widens Portfolio

The latest launch reflects Integra LifeSciences' (IART) consistent efforts to boost the Orthopedics and Tissue Technologies segment.

SRDX : 56.81 (+5.73%)
ATHN : 134.99 (+0.01%)
VEEV : 120.81 (+0.17%)
IART : 51.06 (+0.81%)
Recent Analysis Shows T-Mobile US, Thor Industries, Integra LifeSciences, Diplomat Pharmacy, Tile Shop Hldgs, and Compass Diversified Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of T-Mobile US, Inc. (NASDAQ:TMUS),...

TMUS : 72.05 (+2.20%)
TTS : 7.45 (+3.76%)
IART : 51.06 (+0.81%)
THO : 68.51 (+3.85%)
CODI : 15.83 (+0.13%)
DPLO : 13.75 (-1.01%)
Integra LifeSciences Launches Integra(R) Titan(TM) Reverse Shoulder System-S

Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the full market release of the Integra(R) Titan(TM) Reverse Shoulder System-S (RSS-S)....

IART : 51.06 (+0.81%)
Integra (IART) Rises 5% on Robust Preliminary Q4 Results

Integra's (IART) total Q4 revenues are likely to be at the upper end of its prior guided range.

SRDX : 56.81 (+5.73%)
ATHN : 134.99 (+0.01%)
VEEV : 120.81 (+0.17%)
IART : 51.06 (+0.81%)
Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director

Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the appointment of Rhonda Germany Ballintyn to its board of directors, effective today....

IART : 51.06 (+0.81%)
24.2% Return Seen to Date on SmarTrend Integra Lifescie Call (IART)

SmarTrend identified a Downtrend for Integra Lifescie (NASDAQ:IART) on October 11th, 2018 at $60.49. In approximately 3 months, Integra Lifescie has returned 24.24% as of today's recent price of $45.83....

IART : 51.06 (+0.81%)
Integra Lifescie Rises 2.67% on Heavy Volume: Watch For Potential Pullback

Integra Lifescie (NASDAQ:IART) traded in a range yesterday that spanned from a low of $44.68 to a high of $45.99. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high...

IART : 51.06 (+0.81%)
Integra LifeSciences Announces Agreement with Consortium of Focused Orthopedists to Develop a Short Stem and Stemless Shoulder System

Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced it has signed a license and development agreement with Consortium of Focused Orthopedists,...

IART : 51.06 (+0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade IART with:

Business Summary

Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive and general surgery. Integra's orthopedic...

See More

Key Turning Points

2nd Resistance Point 51.72
1st Resistance Point 51.39
Last Price 51.06
1st Support Level 50.59
2nd Support Level 50.11

See More

52-Week High 67.50
Fibonacci 61.8% 57.81
Fibonacci 50% 54.82
Fibonacci 38.2% 51.83
Last Price 51.06
52-Week Low 42.14

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar